Header Logo

Connection

Sefer Gezer to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Sefer Gezer has written about Tumor Necrosis Factor-alpha.
Connection Strength

0.134
  1. Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma. 2004 Oct; 45(10):2099-104.
    View in: PubMed
    Score: 0.056
  2. Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. Eur J Haematol. 1999 Feb; 62(2):90-4.
    View in: PubMed
    Score: 0.038
  3. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res. 1996 Nov-Dec; 20(11-12):891-900.
    View in: PubMed
    Score: 0.032
  4. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol. 1996 Jun; 63(4):265-78.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.